
|Articles|August 17, 2010
Today's Daily Dose: Immune-mediated hemolytic anemia
Cautions about implementing immune suppression in patients with this disease.
Advertisement
Untitled Document
“The inability to identify an underlying cause for IMHA means that immune suppression remains the mainstay treatment. Concerns about potential negative effects of this immune suppression exist, especially if an occult underlying infectious cause of IMHA was missed during the diagnostic work-up.”
Advertisement
Advertisement
Latest CE
Advertisement
Advertisement
Trending on dvm360
1
Texas couple sentenced for selling smuggled veterinary drugs and pesticides
2
New report examines pet insurance's impact on US veterinary practices
3
Federal judge dismisses Lincoln Memorial University's antitrust lawsuit against the AVMA
4
Two UC Davis clinical trials are recruiting dogs with glioma
5







